Gehen Sie mit der App Player FM offline!
Human Genome Sciences Benlysta Drug Approval for Lupus Patients
Archivierte Serien ("Inaktiver Feed" status)
When? This feed was archived on October 21, 2023 05:48 (). Last successful fetch was on September 28, 2019 01:48 ()
Why? Inaktiver Feed status. Unsere Server waren nicht in der Lage einen gültigen Podcast-Feed für einen längeren Zeitraum zu erhalten.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 151514514 series 1029942
BENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). In June 2010, HGS and GSK submitted regulatory applications seeking approval to market BENLYSTA in the United States and Europe. The FDA has granted BENLYSTA a priority review designation with a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010 – so it is possible that BENLYSTA could receive regulatory approval in the United States before the end of 2010.
5 Episoden
Archivierte Serien ("Inaktiver Feed" status)
When? This feed was archived on October 21, 2023 05:48 (). Last successful fetch was on September 28, 2019 01:48 ()
Why? Inaktiver Feed status. Unsere Server waren nicht in der Lage einen gültigen Podcast-Feed für einen längeren Zeitraum zu erhalten.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 151514514 series 1029942
BENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). In June 2010, HGS and GSK submitted regulatory applications seeking approval to market BENLYSTA in the United States and Europe. The FDA has granted BENLYSTA a priority review designation with a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010 – so it is possible that BENLYSTA could receive regulatory approval in the United States before the end of 2010.
5 Episoden
Alle Folgen
×Willkommen auf Player FM!
Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.